Investor Presentaiton
The measles outbreak response reached 158,285 children aged 9 months to 14 years
nationwide, with financial and technical support from UNICEF. In addition, 52,249 people aged
2 to 29 years were vaccinated against meningitis, and UNICEF provided technical assistance
by facilitation access to the International Coordination Group (ICG) support for vaccines and
operational costs.
Moreover, UNICEF provided emergency assistance to Diffa and Tillabery regions, where
health service delivery was disrupted due to security issues and population movements.
117,110 under-five children were reached with essential health services through fixed and
mobile delivery strategies. Initiatives included support to mobile clinics (reaching 6,788
children) and iCCM in emergencies (reaching 1,288 children).
The major challenges hindering emergency preparedness and response activities included
physical access constraints due to persisting insecurity and difficulties to access hard-to-reach
communities.
HIV and AIDS Outcome: Pregnant women, adolescents and children have access to and
make greater use of quality preventive and curative care services for an AIDS-free
generation
In 2018, UNICEF continued to support Government efforts to fight HIV and AIDS.
Implementing the HIV scale-up plan to accelerate screening, antiretroviral treatment and
prevention of mother-to-child transmission (PMTCT) of HIV led to increased coverage. In
2018, 96% of health facilities including referral hospitals were providing PMTCT services;
however, only 10% of HIV-exposed infants were tested within 2 months of birth (19 babies out
of 198 born from HIV-positive women). This was due to limited access to molecular biology
equipment. To address this situation, UNICEF advocated for the use of GeneXpert Point of
Care machines, which were available in 12 laboratories throughout the country but not used
for HIV testing. UNICEF provided reagents and training for 24 laboratory technicians, resulting
in testing for HIV-exposed infants becoming available in all the regions of the country.
During the first semester of the year, ³ 417,393 pregnant women had attended the first
antenatal consultation and 342,820 among them (82%) received counselling on HIV
prevention and were also tested for HIV. A total of 600 seropositive pregnant women were
recorded, when they did their first antenatal consultation or were about to deliver (some
pregnant women never attend any antenatal consultation before delivery). Among the 600
seropositive women, 387 discovered their HIV status when they underwent testing during ANC
or delivery, and the remaining 213 were already aware of the fact that they were HIV-positive.
536 among them received antiretroviral treatment or prophylaxis for the treatment and
prevention of mother-to-child transmission of HIV; reaching 89.33% coverage. However, out
of the 600 seropositive women, only 213 were receiving long-lasting antiretroviral treatment.
Also during the first semester of 2018 in Niger, 116 out of 198 newborns at risk of contracting
HIV received antiretroviral prophylaxis in accordance to PMTCT guidelines, representing a
58.6% coverage.
Output 2.1: By 2018, health facilities offer adequate, integrated services to adolescents
at risk of HIV infection; PMTCT for pregnant women and exposed newborns; and case
management for children and adolescents infected with HIV.
In the health districts located in convergence municipalities, 81,453 (72%) pregnant women
have been tested during the first ANC (with a seroprevalence of 0,13%) out of the 112,840
3 Latest data available from the Ministry of Health
14View entire presentation